Skip to main content
Top
Published in: Annals of Hematology 7/2020

01-07-2020 | Thalassemia | Original Article

Genotypic-phenotypic heterogeneity of δβ-thalassemia and hereditary persistence of fetal hemoglobin (HPFH) in India

Authors: Priya Hariharan, Pooja Kishnani, Pratibha Sawant, Manju Gorivale, Pallavi Mehta, Neha Kargutkar, Roshan Colah, Anita Nadkarni

Published in: Annals of Hematology | Issue 7/2020

Login to get access

Abstract

Large deletions in the β-globin gene cluster lead to increased HbF levels by delaying the γ- to β-globin switch process. However, these deletions when inherited as a homozygous condition or when co-inherited with β-thalassemia result in variable clinical phenotypes. Individuals or families with a clinically presenting child, where the parents had HbF levels ≥ 10%, were further screened for the presence of large β-globin cluster deletions. Six deletions in the β-globin gene cluster were screened by GAP-PCR, and the uncharacterized deletions were further analyzed by gene dosage or by multiplex ligation-dependent probe amplification (MLPA). Among 192 individuals suspected for the inheritance of large deletions, 138 were heterozygous for large deletions, 45 were compound heterozygous of a large β-globin cluster deletion and β-thalassemia, and 9 were found to be homozygous for deletions. Among the heterozygotes, the Asian Indian inversion-deletion was found to be the most common deletion (39.9%), followed by the HPFH-3 deletion (30.0%). Other deletions 49.3 kb, δβ-thalassemia (21.2%), and 32.6 kb deletion (4.4%) were also found to be prevalent in our population. Patients compound heterozygous or homozygous for HPFH-3 and 32.6 kb deletions showed a milder clinical presentation, as compared with the patients compound heterozygous or homozygous for the Asian Indian inversion-deletion and 49.3 kb δβ-thalassemia. This comprehensive study highlights the mutation spectrum of large β-globin cluster deletions and the clinical heterogeneity in the patients homozygous or compound heterozygous with β-thalassemia, thus asserting the need for molecular characterization of these deletions.
Literature
3.
go back to reference Wood W (2001) Hereditary persistence of fetal hemoglobin and δβ thalassemia. In: Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Cambridge University Press. 1,356 Wood W (2001) Hereditary persistence of fetal hemoglobin and δβ thalassemia. In: Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Cambridge University Press. 1,356
12.
go back to reference Fucharoen S, Pengjam Y, Surapot S, Fucharoen G, Sanchaisuriya K (2002) Molecular and hematological characterization of HPFH-6/Indian deletion–inversion Gγ (Aγδβ) 0-thalassemia and Gγ (Aγδβ) 0-thalassemia/HbE in Thai patients. Am J Hematol 2:109–113. https://doi.org/10.1002/ajh.10202 CrossRef Fucharoen S, Pengjam Y, Surapot S, Fucharoen G, Sanchaisuriya K (2002) Molecular and hematological characterization of HPFH-6/Indian deletion–inversion Gγ (Aγδβ) 0-thalassemia and Gγ (Aγδβ) 0-thalassemia/HbE in Thai patients. Am J Hematol 2:109–113. https://​doi.​org/​10.​1002/​ajh.​10202 CrossRef
19.
go back to reference Anagnou N, Perez-Stable C, Gelinas G, Costantini C, Liapaki L, Constantopoulou C et al (1995) Sequences located 3′ to the breakpoint of the hereditary persistence of fetal hemoglobin-3 deletion exhibit enhancer activity and can modify the developmental expression of the human fetal Aγ-globin gene in transgenic mice. J Biol Chem 270:10256–10263. https://doi.org/10.1074/jbc.270.17.10256 CrossRefPubMed Anagnou N, Perez-Stable C, Gelinas G, Costantini C, Liapaki L, Constantopoulou C et al (1995) Sequences located 3′ to the breakpoint of the hereditary persistence of fetal hemoglobin-3 deletion exhibit enhancer activity and can modify the developmental expression of the human fetal Aγ-globin gene in transgenic mice. J Biol Chem 270:10256–10263. https://​doi.​org/​10.​1074/​jbc.​270.​17.​10256 CrossRefPubMed
22.
23.
go back to reference Antoniani C, Meneghini V, Lattanzi A, Felix T, Romano O, Magrin E, Weber L, Pavani G, el Hoss S, Kurita R, Nakamura Y, Cradick TJ, Lundberg AS, Porteus M, Amendola M, el Nemer W, Cavazzana M, Mavilio F, Miccio A (2018) Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus. Blood 131:1960–1973. https://doi.org/10.1182/blood-2017-10-811505 CrossRefPubMed Antoniani C, Meneghini V, Lattanzi A, Felix T, Romano O, Magrin E, Weber L, Pavani G, el Hoss S, Kurita R, Nakamura Y, Cradick TJ, Lundberg AS, Porteus M, Amendola M, el Nemer W, Cavazzana M, Mavilio F, Miccio A (2018) Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus. Blood 131:1960–1973. https://​doi.​org/​10.​1182/​blood-2017-10-811505 CrossRefPubMed
24.
go back to reference Zeng Y, Huang S, Chen B, Liang Y, Chang Z, Harano T, et al (1985) Hereditary persistence of fetal hemoglobin or (delta beta) o-thalassemia: three types observed in south-Chinesefamilies. Blood 66:1430-5. DOI:10.1182/blood.V66.6.1430.bloodjournal, 6661430 Zeng Y, Huang S, Chen B, Liang Y, Chang Z, Harano T, et al (1985) Hereditary persistence of fetal hemoglobin or (delta beta) o-thalassemia: three types observed in south-Chinesefamilies. Blood 66:1430-5. DOI:10.1182/blood.V66.6.1430.bloodjournal, 6661430
Metadata
Title
Genotypic-phenotypic heterogeneity of δβ-thalassemia and hereditary persistence of fetal hemoglobin (HPFH) in India
Authors
Priya Hariharan
Pooja Kishnani
Pratibha Sawant
Manju Gorivale
Pallavi Mehta
Neha Kargutkar
Roshan Colah
Anita Nadkarni
Publication date
01-07-2020
Publisher
Springer Berlin Heidelberg
Keyword
Thalassemia
Published in
Annals of Hematology / Issue 7/2020
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-020-04081-8

Other articles of this Issue 7/2020

Annals of Hematology 7/2020 Go to the issue